APPROVED MEDICINES
NEUROLOGY
XCOPRI® (cenobamate tablets) CV
XCOPRI is a prescription anti-seizure medicine indicated for the treatment of partial-onset seizures (also called focal seizures) in adults.
Partial-onset seizures are caused by irregular electrical activity that begins on one side of the brain. Seizure symptoms may include uncontrolled movements and muscle twitches.
XCOPRI is thought to work via a multimodal mechanism of action. XCOPRI has been demonstrated to reduce repetitive neuronal firing by inhibiting voltage-gated sodium currents, including inhibiting the persistent component of the sodium current. It is also a positive allosteric modulator of the γ-aminobutyric acid (GABAA) ion channel.